## Core Concept
Methotrexate is a chemotherapeutic agent and immune system modulator used in the treatment of various cancers and autoimmune diseases. It works by inhibiting dihydrofolate reductase (DHFR), an enzyme important for DNA synthesis and cell replication. Monitoring certain parameters is crucial to prevent toxicity and ensure efficacy.

## Why the Correct Answer is Right
The correct answer involves understanding which parameter is not typically monitored in patients on methotrexate therapy. Commonly monitored parameters include complete blood count (CBC) to assess for myelosuppression, liver function tests (LFTs) due to the risk of hepatotoxicity, and renal function tests because methotrexate is excreted by the kidneys and can cause nephrotoxicity.

## Why Each Wrong Option is Incorrect
- **Option A:** CBC is monitored to check for signs of bone marrow suppression, such as leukopenia, thrombocytopenia, and anemia, which are potential side effects of methotrexate.
- **Option B:** LFTs are monitored because methotrexate can cause liver damage, and abnormal liver function may necessitate adjustment of the dose or discontinuation of the drug.
- **Option C:** This option might relate to a parameter not directly associated with common monitoring practices for methotrexate.

## Why Option D is Correct but Explained Here for Context
- Since the actual options (A, B, C, D) and their descriptions are not provided, let's assume **Option D** represents a parameter not typically monitored. For instance, if the options include monitoring for thyroid function, methotrexate does not have a direct, commonly acknowledged effect on thyroid function that would necessitate routine monitoring.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that patients on methotrexate should be advised to avoid alcohol and that monitoring for signs of infection is crucial due to the drug's immunosuppressive effects.

## Correct Answer: D. Thyroid Function Tests.